MN SF3970

Authorizes incentives for pharmaceutical manufacturers that import multimarket-approved (MMA) products under FDA importation guidance, establishing new law in Minnesota Statutes chapter 62J.

Defines MMA products as FDA-approved drugs manufactured outside the United States, authorized for marketing by another country's regulatory authority, and imported with a new National Drug Code.

Requires MMA products offered for sale in Minnesota at least 23 percent lower than the wholesale acquisition cost for the same U.S.-manufactured drug to be included on the uniform preferred drug list and covered under medical assistance and MinnesotaCare programs.

Mandates health plan companies provide coverage for qualifying MMA products without enrollee cost-sharing requirements if the U.S.-manufactured version is covered by the plan.

Incentives provisions do not become effective unless affirmative action is taken by the legislature.